Exploratory Study of Venetoclax, Homoharringtonine, Azacitidine Plus G-CSF for Newly Diagnosed AML (VHAG)

Clinical trial NCT07507825 · NOT_YET_RECRUITING

Trial details

NCT number

NCT07507825

Sponsor

First People's Hospital of Hangzhou

Status

NOT_YET_RECRUITING

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2026-03-31

Primary completion

2028-03-31

Enrollment

61

View on ClinicalTrials.gov